FDA Inspection
Veltek Associates, Inc.Veltek Associates, Inc. – FDA Inspection, Nov 14, 2018
Record Details
This FDA Inspection record concerns Veltek Associates, Inc., with an inspection on November 14, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 98cc84b7-0da0-4e61-af76-933e738e683b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1071613
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Veltek Associates, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 6, 2025 | VAI | Philadelphia District Office | Drug Quality Assurance |
| September 30, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Veltek Associates, Inc.
- FDA Inspection 1260259 - 2025-02-06
- FDA Inspection 850761 - 2013-09-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.